Project Number PTC-17-445974 Agency/Funding Organization Alzheimer's Association Funding Year 2017 View Full Project Details for Phase 1b MAD Study of a Novel Drug (MW189) Targeting Neuroinflammation Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) f. Inflammation Researcher and Organization Principal Investigator Van Eldik, Linda Principal Investigator First Name Linda Principal Investigator Last Name Van Eldik Awardee Organization UNIVERSITY OF KENTUCKY Awardee State Kentucky Contact PI Country United States Project Detail Funding Opportunity Announcement PA 2017: PTC RFA FY Overall Cost $997,738 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Snyder, Heather hsnyder@alz.org
